Pierobon M - Search Results

1

Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.

Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, Tarney CM, Crothers BA, Mhawech-Fauceglia P, Dalgard CL, Wilkerson MD, Pierobon M, Petricoin EF, Yan C, Meerzaman D, Bodelon C, Wentzensen N, Lee JSH; APOLLO Research Network; Huntsman DG, Shah S, Shriver CD, Phippen NT, Darcy KM, Bowtell DDL, Conrads TP, Maxwell GL. Bateman NW, et al. Among authors: pierobon m. NPJ Precis Oncol. 2024 Mar 13;8(1):68. doi: 10.1038/s41698-024-00519-8. NPJ Precis Oncol. 2024. PMID: 38480868 Free PMC article.

2

Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region.

Zavagno G, De Salvo GL, Casara D, Del Bianco P, Rubello D, Meggiolaro F, Rossi CR, Pierobon M, Lise M. Zavagno G, et al. Among authors: pierobon m. BMC Cancer. 2004 Jan 22;4:2. doi: 10.1186/1471-2407-4-2. BMC Cancer. 2004. PMID: 14736337 Free PMC article.

3

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.

Zavagno G, Carcoforo P, Marconato R, Franchini Z, Scalco G, Burelli P, Pietrarota P, Lise M, Mencarelli R, Capitanio G, Ballarin A, Pierobon ME, Marconato G, Nitti D. Zavagno G, et al. Among authors: pierobon me. BMC Cancer. 2005 Mar 11;5:28. doi: 10.1186/1471-2407-5-28. BMC Cancer. 2005. PMID: 15762990 Free PMC article.

4

Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and Response.

Jacobsen KH, Aguirre AA, Bailey CL, Baranova AV, Crooks AT, Croitoru A, Delamater PL, Gupta J, Kehn-Hall K, Narayanan A, Pierobon M, Rowan KE, Schwebach JR, Seshaiyer P, Sklarew DM, Stefanidis A, Agouris P. Jacobsen KH, et al. Among authors: pierobon m. Ecohealth. 2016 Mar;13(1):200-12. doi: 10.1007/s10393-016-1100-5. Epub 2016 Feb 25. Ecohealth. 2016. PMID: 26915507 Free PMC article. Review.

5

Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.

VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF 3rd. VanMeter A, et al. Among authors: pierobon m. Expert Rev Mol Diagn. 2007 Sep;7(5):625-33. doi: 10.1586/14737159.7.5.625. Expert Rev Mol Diagn. 2007. PMID: 17892368 Review.

6

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.

Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX, Swain SM, Nitti D, Esserman LJ, Belluco C, Liotta LA, Petricoin EF 3rd. Wulfkuhle JD, et al. Among authors: pierobon m. J Proteome Res. 2008 Apr;7(4):1508-17. doi: 10.1021/pr7008127. Epub 2008 Feb 8. J Proteome Res. 2008. PMID: 18257519

7

Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker.

Pierobon M, Calvert V, Belluco C, Garaci E, Deng J, Lise M, Nitti D, Mammano E, Marchi FD, Liotta L, Petricoin E. Pierobon M, et al. Clin Colorectal Cancer. 2009 Mar;8(2):110-7. doi: 10.3816/CCC.2009.n.018. Clin Colorectal Cancer. 2009. PMID: 19423505

8

Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker.

Pierobon M, Calvert V, Belluco C, Garaci E, Deng J, Lise M, Nitti D, Mammano E, De Marchi F, Liotta L, Petricoin E. Pierobon M, et al. Clin Colorectal Cancer. 2009 Apr;8(2):110-7. doi: 10.3816/CCC.2009.n.018. Clin Colorectal Cancer. 2009. PMID: 19739273

9

Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.

Silvestri A, Colombatti A, Calvert VS, Deng J, Mammano E, Belluco C, De Marchi F, Nitti D, Liotta LA, Petricoin EF, Pierobon M. Silvestri A, et al. Among authors: pierobon m. Lab Invest. 2010 May;90(5):787-96. doi: 10.1038/labinvest.2010.47. Epub 2010 Mar 1. Lab Invest. 2010. PMID: 20195244 Free article.

10

Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?

Fodale V, Pierobon M, Liotta L, Petricoin E. Fodale V, et al. Among authors: pierobon m. Cancer J. 2011 Mar-Apr;17(2):89-95. doi: 10.1097/PPO.0b013e318212dd3d. Cancer J. 2011. PMID: 21427552 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page